These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome. Samlowski WE, Kondapaneni M, Tharkar S, McGregor JR, Laubach VE, Salvemini D. J Immunother; 2011 Jun; 34(5):419-27. PubMed ID: 21577143 [Abstract] [Full Text] [Related]
3. The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice. Orucevic A, Hearn S, Lala PK. Lab Invest; 1997 Jan; 76(1):53-65. PubMed ID: 9010449 [Abstract] [Full Text] [Related]
5. Histamine improves survival and protects against interleukin-2-induced pulmonary vascular leak syndrome in mice. Hornyak SC, Orentas DM, Karavodin LM, Gehlsen KR. Vascul Pharmacol; 2005 Mar; 42(4):187-93. PubMed ID: 15820445 [Abstract] [Full Text] [Related]
6. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. Schlüter D, Deckert-Schlüter M, Lorenz E, Meyer T, Röllinghoff M, Bogdan C. J Immunol; 1999 Mar 15; 162(6):3512-8. PubMed ID: 10092808 [Abstract] [Full Text] [Related]
7. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV. Invest Ophthalmol Vis Sci; 2007 Nov 15; 48(11):5257-65. PubMed ID: 17962481 [Abstract] [Full Text] [Related]
12. Effect of inhibition of inducible nitric oxide synthase (iNOS) on the murine splenic immune response induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans lipopolysaccharide. Sosroseno W, Musa M, Ravichandran M, Ibrahim MF, Bird PS, Seymour GJ. Eur J Oral Sci; 2008 Feb 15; 116(1):31-6. PubMed ID: 18186729 [Abstract] [Full Text] [Related]
13. Nitric oxide cooperates with glucocorticoids in thymic epithelial cell-mediated apoptosis of double positive thymocytes. Cohen O, Kfir-Erenfeld S, Spokoini R, Zilberman Y, Yefenof E, Sionov RV. Int Immunol; 2009 Oct 15; 21(10):1113-23. PubMed ID: 19692538 [Abstract] [Full Text] [Related]
14. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. Rafi-Janajreh AQ, Chen D, Schmits R, Mak TW, Grayson RL, Sponenberg DP, Nagarkatti M, Nagarkatti PS. J Immunol; 1999 Aug 01; 163(3):1619-27. PubMed ID: 10415067 [Abstract] [Full Text] [Related]
15. Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice. Wu L, Mayeux PR. J Pharmacol Exp Ther; 2007 Mar 01; 320(3):1061-7. PubMed ID: 17202403 [Abstract] [Full Text] [Related]
16. A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects. Samlowski WE, Petersen R, Cuzzocrea S, Macarthur H, Burton D, McGregor JR, Salvemini D. Nat Med; 2003 Jun 01; 9(6):750-5. PubMed ID: 12730689 [Abstract] [Full Text] [Related]
17. Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome. Assier E, Jullien V, Lefort J, Moreau JL, Vargaftig BB, Lapa e Silva JR, Thèze J. Cytokine; 2005 Dec 21; 32(6):280-6. PubMed ID: 16378732 [Abstract] [Full Text] [Related]
18. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide. Katada K, Bihari A, Badhwar A, Yoshida N, Yoshikawa T, Potter RF, Cepinskas G. J Pharmacol Exp Ther; 2009 Jun 21; 329(3):919-27. PubMed ID: 19270191 [Abstract] [Full Text] [Related]
19. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite. Kawano T, Kunz A, Abe T, Girouard H, Anrather J, Zhou P, Iadecola C. J Cereb Blood Flow Metab; 2007 Aug 21; 27(8):1453-62. PubMed ID: 17293848 [Abstract] [Full Text] [Related]
20. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. Rosenstein M, Ettinghausen SE, Rosenberg SA. J Immunol; 1986 Sep 01; 137(5):1735-42. PubMed ID: 3528289 [Abstract] [Full Text] [Related] Page: [Next] [New Search]